NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

反轉錄病毒快速·POC (照護現場) 檢驗的全球市場:醫療設備的開發平台評估

Retrovirus Tests - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 556492
出版日期 內容資訊 英文 140 Pages
訂單完成後即時交付
價格
反轉錄病毒快速·POC (照護現場) 檢驗的全球市場:醫療設備的開發平台評估 Retrovirus Tests - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年11月30日內容資訊: 英文 140 Pages
簡介

本報告提供全球反轉錄病毒快速檢驗及POC (照護現場) 實驗之相關產品市場上主要開發中產品及其臨床實驗進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,同時彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 反轉錄病毒快速·POC (照護現場) 檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 反轉錄病毒迅速·POC檢驗的企業:各臨床實驗階段的開發中產品
  • 反轉錄病毒迅速·POC檢驗:各臨床實驗階段的開發中產品

第5章 反轉錄病毒迅速·POC檢驗市場:企業·產品概要 (全39公司份)

  • Akers Biosciences Inc
    • 開發中產品及進行中的臨床實驗概要
  • Aldatu Biosciences, Inc.
  • Atomo Diagnostics Pty Limited
  • BBB Technologies Inc
  • Bio-Alternative Medical Devices Ltd
  • Biocartis SA
  • Biosynex SA
  • Calypte Biomedical Corporation
  • Centre International de Reference Chantal Biya
  • Cepheid
  • Chembio Diagnostic Systems Inc
  • Daktari Diagnostics, Inc.
  • Diagnostics For All
  • Diagnostics for the Real World (Europe) Ltd.
  • Epinex Diagnostics Inc
  • ERBA Molecular Ltd
  • GAIA Medical Institute LLC
  • genedrive plc
  • Group K Diagnostics
  • HeatFlow Technologies Inc
  • Jinvator Bio Med GmbH
  • John Hopkins University
  • Labsystems Diagnostics Oy
  • Micronics Inc
  • Molbio Diagnostics Pvt. Ltd.
  • Northwestern Global Health Foundation
  • NOWDiagnostics
  • Omega Diagnostics Group Plc
  • OPKO Health Inc
  • OraSure Technologies Inc
  • Osel Inc
  • 5.32. QuantuMDx Group Ltd
  • Quidel Corp
  • Radisens Diagnostics Ltd
  • Rheonix Inc
  • Roche Diagnostics International Ltd
  • Sedia Biosciences Corp
  • Trinity Biotech Plc
  • Wave 80 Biosciences Inc

第6章 反轉錄病毒迅速·POC檢驗市場:目前的趨勢 (全27件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1052EPD

GlobalData's Medical Devices sector report, "Retrovirus Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Retrovirus Tests are the diagnostic tests used to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Retrovirus Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Retrovirus Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Retrovirus Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Retrovirus Tests Overview

3 Products under Development

  • 3.1 Retrovirus Tests - Pipeline Products by Stage of Development
  • 3.2 Retrovirus Tests - Pipeline Products by Territory
  • 3.3 Retrovirus Tests - Pipeline Products by Regulatory Path
  • 3.4 Retrovirus Tests - Pipeline Products by Estimated Approval Date

4 Retrovirus Tests - Pipeline Products under Development by Companies

  • 4.1 Retrovirus Tests Companies - Pipeline Products by Stage of Development
  • 4.2 Retrovirus Tests - Pipeline Products by Stage of Development

5 Retrovirus Tests Companies and Product Overview

6 Retrovirus Tests- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Retrovirus Tests - Pipeline Products by Stage of Development
  • Table 2: Retrovirus Tests - Pipeline Products by Territory
  • Table 3: Retrovirus Tests - Pipeline Products by Regulatory Path
  • Table 4: Retrovirus Tests - Pipeline Products by Estimated Approval Date
  • Table 5: Retrovirus Tests Companies - Pipeline Products by Stage of Development
  • Table 6: Retrovirus Tests - Pipeline Products by Stage of Development
  • Table 7: Accelevir Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Diagnostic Test - Latent HIV-1 Virus - Product Status
  • Table 9: Diagnostic Test - Latent HIV-1 Virus - Product Description
  • Table 10: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Portable Benchtop Analyzer - Viral Load Assay - Product Status
  • Table 12: Portable Benchtop Analyzer - Viral Load Assay - Product Description
  • Table 13: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: AIMS System - HIV-1 Test - Product Status
  • Table 15: AIMS System - HIV-1 Test - Product Description
  • Table 16: AtheNA Multi-Lyte System - HIV-1 Test - Product Status
  • Table 17: AtheNA Multi-Lyte System - HIV-1 Test - Product Description
  • Table 18: Allied Innovative Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: HIV p24 Antigen ELISA - Product Status
  • Table 20: HIV p24 Antigen ELISA - Product Description
  • Table 21: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Viral Protein Antibody Test - Non-HIV AIDS - Product Status
  • Table 23: Viral Protein Antibody Test - Non-HIV AIDS - Product Description
  • Table 24: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: DETECTHIV - Product Status
  • Table 26: DETECTHIV - Product Description
  • Table 27: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Status
  • Table 29: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Description
  • Table 30: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Diagnostic Test - HIV - Product Status
  • Table 32: Diagnostic Test - HIV - Product Description
  • Table 33: IOBS - HIV Diagnostic Test - Product Status
  • Table 34: IOBS - HIV Diagnostic Test - Product Description
  • Table 35: Blackfly Investments LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Molecular RNA Test - HIV - Product Status
  • Table 37: Molecular RNA Test - HIV - Product Description
  • Table 38: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Second Generation Incidence Test - HIV - Product Status
  • Table 40: Second Generation Incidence Test - HIV - Product Description
  • Table 41: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Diagnostic Test - HIV - Product Status
  • Table 43: Diagnostic Test - HIV - Product Description
  • Table 44: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: CD4 Assay - HIV - Product Status
  • Table 46: CD4 Assay - HIV - Product Description
  • Table 47: Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: HIV RNA Real-time PCR Kit - Product Status
  • Table 49: HIV RNA Real-time PCR Kit - Product Description
  • Table 50: Conrad Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Biomarker - HIV Acquisition - Product Status
  • Table 52: Biomarker - HIV Acquisition - Product Description
  • Table 53: Biomarker - Hormonal Contraception - Product Status

List of Figures

List of Figures

  • Figure 1: Retrovirus Tests - Pipeline Products by Stage of Development
  • Figure 2: Retrovirus Tests - Pipeline Products by Territory
  • Figure 3: Retrovirus Tests - Pipeline Products by Regulatory Path
  • Figure 4: Retrovirus Tests - Pipeline Products by Estimated Approval Date